Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fulesdi, B.
Right arrow Articles by Csiba, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fulesdi, B.
Right arrow Articles by Csiba, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 11 1840-1845, Copyright © 1997 by American Diabetes Association


ARTICLES

Impairment of cerebrovascular reactivity in long-term type 1 diabetes

B Fulesdi, M Limburg, D Bereczki, RP Michels, G Neuwirth, D Legemate, A Valikovics and L Csiba
Department of Neurology, University Medical School of Debrecen, Hungary. fulesdi@ideg.dote.hu

The early preclinical detection of cerebrovascular complications in individuals with diabetes is one of the goals of care described in the St. Vincent Declaration. In accordance with this goal, the aim of the present work was to investigate whether altered cerebral microvascular function in patients suffering from type 1 diabetes can be detected with a transcranial Doppler probe after the administration of acetazolamide. A total of 72 type 1 diabetic patients and 40 healthy control subjects entered the study. Patients were divided into two groups: those with long-term diabetes (disease duration of >10 years, n = 37) and those with short-term diabetes (disease duration of < or =10 years, n = 35). Mean blood-flow velocity in the middle cerebral artery (MCAV) was measured at rest and at 5, 10, 15, and 20 min after intravenous administration of 1 g acetazolamide with a transcranial Doppler probe and expressed as the percentage change from the pretest measurement. The percentage increase in MCAV (cerebrovascular reactivity) was calculated at each time point and compared between the groups. Cerebrovascular reserve capacity (CRC), expressed as the maximal percentage increase of the MCAV, was compared between the groups. Additionally, a reproducibility study of CRC was performed in 10 patients, using intraclass correlations. Cerebrovascular reactivity in the long-term diabetes group was lower (means +/- SD: 5 min, 23.4 +/- 15.4%; 10 min, 28.8 +/- 17.0%; 15 min, 30.0 +/- 15.6%; 20 min, 24.2 +/- 17.8%) than that of the control subjects (5 min, 43.5 +/- 23.9%; 10 min, 55.3 +/- 24.0%; 15 min, 56.7 +/- 23.8%; 20 min, 54.8 +/- 25.9%) and the short-term diabetic patients (5 min, 43.6 +/- 25.9%; 10 min, 52.2 +/- 27.7%; 15 min, 55.3 +/- 32.2%; 20 min, 45.8 +/- 35.8%). CRC was lower in the long-term diabetes group than in the control group or the short-term diabetes group. Impairment of cerebrovascular reactivity was associated with retino- and nephropathy and increased levels of fibrinogen. In contrast, CRC was independent from actual glucose, insulin, glycosylated hemoglobin, von Willebrand factor antigen, and alpha-2 macroglobulin levels. Transcranial Doppler measurements of the changes in MCAV after stimulation with acetazolamide can detect altered cerebral microvascular function in patients with diabetes. Cerebrovascular reactivity and reserve capacity are reduced in patients with long-term diabetes. Further prospective studies should delineate the clinical significance of our results.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. M. Wessels, S. A.R.B. Rombouts, S. Simsek, J. P.A. Kuijer, P. J. Kostense, F. Barkhof, P. Scheltens, F. J. Snoek, and R. J. Heine
Microvascular Disease in Type 1 Diabetes Alters Brain Activation: A Functional Magnetic Resonance Imaging Study
Diabetes, February 1, 2006; 55(2): 334 - 340.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Walters, S. Muir, I. Shah, and K. Lees
Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction
Stroke, August 1, 2004; 35(8): 1899 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
P. Neu, P. Schlattmann, A. Schilling, and A. Hartmann
Cerebrovascular Reactivity in Major Depression: A Pilot Study
Psychosom Med, January 1, 2004; 66(1): 6 - 8.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. C. Ferguson, A. Blane, P. Perros, R. J. McCrimmon, J. J.K. Best, J. Wardlaw, I. J. Deary, and B. M. Frier
Cognitive Ability and Brain Structure in Type 1 Diabetes: Relation to Microangiopathy and Preceding Severe Hypoglycemia
Diabetes, January 1, 2003; 52(1): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. A. Luchsinger, M.-X. Tang, Y. Stern, S. Shea, and R. Mayeux
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Am. J. Epidemiol., October 1, 2001; 154(7): 635 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Tantucci, P. Bottini, C. Fiorani, M. L. Dottorini, F. Santeusanio, L. Provinciali, C. A. Sorbini, and G. Casucci
Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy
J Appl Physiol, March 1, 2001; 90(3): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. J. Carey, P. J. Eames, M. J. Blake, R. B. Panerai, and J. F. Potter
Dynamic Cerebral Autoregulation Is Unaffected by Aging
Stroke, December 1, 2000; 31(12): 2895 - 2900.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Y. Lee, Y. H. Sohn, J. S. Baik, G. W. Kim, and J.-S. Kim
Arterial Pulsatility as an Index of Cerebral Microangiopathy in Diabetes
Stroke, May 1, 2000; 31(5): 1111 - 1115.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Molina, J. A. Sabin, J. Montaner, A. Rovira, S. Abilleira, and A. Codina
Impaired Cerebrovascular Reactivity as a Risk Marker for First-Ever Lacunar Infarction : A Case-Control Study
Stroke, November 1, 1999; 30 (11): 2296 - 2301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.